AbCellera Biologics (ABCL) Selling, General & Administrative (2020 - 2026)
AbCellera Biologics (ABCL) posted Selling, General & Administrative of $13.85 million for Q2 2026, down 37.0% from $21.99 million a year earlier but up 12.3% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Selling, General & Administrative (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at AbCellera Biologics was $74.21 million, down 16.6% year-over-year; for FY2025, it came in at $83.23 million, down 2.6% from FY2024.
- Annual Selling, General & Administrative shows a five-year compound annual growth rate of 47.5% (FY2020 to FY2025).
- In prior years, AbCellera Biologics' Selling, General & Administrative was $85.49 million in FY2024 (+13.7%), $75.18 million in FY2023 (+35.5%), $55.49 million in FY2022 (+32.6%) and $41.85 million in FY2021 (+251.4%).
- Quarterly Selling, General & Administrative has run from a low of $11.27 million in Q3 2021 to a high of $30.15 million in Q4 2023 over five years.
- On a year-over-year basis, Selling, General & Administrative has declined in each of the last three quarters, with an average decline of 2.4% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 279.8%; the weakest was Q2 2026, with a decline of 37.0%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $12.33 million (Q1 2026), $25.98 million (Q4 2025) and $22.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 582.20 Mn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - | 13.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.85 Mn |
| Mar 31, 2026 | 12.33 Mn |
| Dec 31, 2025 | 25.98 Mn |
| Sep 30, 2025 | 22.05 Mn |
| Jun 30, 2025 | 21.99 Mn |
| Mar 31, 2025 | 19.07 Mn |
| Dec 31, 2024 | 28.80 Mn |
| Sep 30, 2024 | 19.15 Mn |
| Jun 30, 2024 | 20.19 Mn |
| Mar 31, 2024 | 17.35 Mn |
| Dec 31, 2023 | 30.15 Mn |
| Sep 30, 2023 | 14.37 Mn |
| Jun 30, 2023 | 15.52 Mn |
| Mar 31, 2023 | 15.13 Mn |
| Dec 31, 2022 | 13.02 Mn |
| Sep 30, 2022 | 13.79 Mn |
| Jun 30, 2022 | 14.41 Mn |
| Mar 31, 2022 | 14.27 Mn |
| Dec 31, 2021 | 12.89 Mn |
| Sep 30, 2021 | 11.27 Mn |
API Access
AbCellera Biologics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();